Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-11

Clinical Trial Update: Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an elemental diet for inflammatory bowel disease in patients with chronic granulomatous disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elemental Diet (elemental diet)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease, Inflammatory Bowel Disease | Phase 2 | Status: COMPLETED